GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in GH Research PLC as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +6 vs. Q4 2024
- Shares held
- 42.6M
- +11.9M (+38.8%) vs. Q4 2024
- Total value
- $470.1M
- +$255.2M (+118.7%) vs. Q4 2024
- New holders
- 14
- 10 more added
- Sold out
- 8
- 8 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $1.38B |
| Q1 2026 | 54 | $668.5M |
| Q4 2025 | 53 | $591.4M |
| Q3 2025 | 47 | $618.1M |
| Q2 2025 | 38 | $530.9M |
| Q1 2025 | 36 | $470.1M |
| Q4 2024 | 31 | $214.9M |
| Q3 2024 | 28 | $204.2M |
| Q2 2024 | 28 | $354.8M |
| Q1 2024 | 32 | $315.5M |
| Q4 2023 | 35 | $171.7M |
| Q3 2023 | 29 | $291.5M |
| Q2 2023 | 34 | $351.6M |
| Q1 2023 | 29 | $237.2M |
| Q4 2022 | 32 | $299.5M |
| Q3 2022 | 34 | $367.2M |
| Q2 2022 | 35 | $325.0M |
| Q1 2022 | 33 | $587.1M |
| Q4 2021 | 30 | $701.0M |
| Q3 2021 | 30 | $625.2M |
| Q2 2021 | 34 | $593.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding GH Research PLC; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 8,827,712 | $97.4M | 3.97% | −1,572,446−15.1% | Reduced |
| Ra Capital Management, L.P. | 6,944,648 | $76.6M | 1.28% | +257,959+3.9% | Added |
| Lynx1 Capital Management LP | 6,443,940 | $71.1M | 25.45% | +1,584,946+32.6% | Added |
| RTW Investments, LP | 5,499,769 | $60.7M | 0.93% | +2,172,640+65.3% | Added |
| FMR LLC | 4,249,580 | $46.9M | 0.00% | +1,762,210+70.8% | Added |
| Cormorant Asset Management, LP | 2,009,482 | $22.2M | 1.68% | +1,416,439+238.8% | Added |
| Deep Track Capital, LP | 2,000,000 | $22.1M | 0.71% | +2,000,000 | New |
| Toronto Dominion Bank | 1,967,293 | $21.7M | 0.06% | +1,967,293 | New |
| Deerfield Management Company, L.P. (Series C) | 925,000 | $10.2M | 0.20% | +925,000 | New |
| Jefferies Financial Group Inc. | 750,000 | $8.27M | 0.14% | +750,000 | New |
| Verition Fund Management LLC | 670,605 | $7.40M | 0.04% | −247,194−26.9% | Reduced |
| 5AM Venture Management, LLC | 572,665 | $6.32M | 2.39% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 454,975 | $5.02M | 0.02% | +454,975 | New |
| UBS Group AG | 447,934 | $4.94M | 0.00% | +426,707+2,010.2% | Added |
| Morgan Stanley | 277,251 | $3.06M | 0.00% | +11,783+4.4% | Added |
| Troluce Capital Advisors LLC | 155,597 | $1.72M | 1.62% | +155,597 | New |
| Geode Capital Management, LLC | 67,215 | $741.4K | 0.00% | −5,298−7.3% | Reduced |
| PEAK6 LLC | 64,213 | $708.3K | 0.03% | +5,013+8.5% | Added |
| Walleye Capital LLC | 52,940 | $583.9K | 0.01% | +52,940 | New |
| BlackRock, Inc. | 43,971 | $485.0K | 0.00% | −3,243−6.9% | Reduced |
| Northern Trust Corp | 39,331 | $433.8K | 0.00% | −1,503−3.7% | Reduced |
| AdvisorShares Investments LLC | 33,256 | $357.8K | 0.07% | −2,755−7.7% | Reduced |
| Quadrature Capital Ltd | 31,625 | $347.9K | 0.01% | +31,625 | New |
| Boothbay Fund Management, LLC | 29,914 | $330.0K | 0.01% | +29,914 | New |
| Citadel Advisors LLC | 15,586 | $171.9K | 0.00% | +15,586 | New |
| XTX Topco Ltd | 15,354 | $169.4K | 0.01% | +15,354 | New |
| Palumbo Wealth Management LLC | 12,869 | $141.9K | 0.05% | +12,869 | New |
| BNP Paribas Arbitrage, SA | 6,410 | $70.7K | 0.00% | +100+1.6% | Added |
| Advisor Group Holdings, Inc. | 3,775 | $41.6K | 0.00% | −1,275−25.2% | Reduced |
| Tortoise Investment Management, LLC | 1,781 | $19.6K | 0.00% | 00.0% | Unchanged |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 2,000 | $19.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,250 | $13.8K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,100 | $12.0K | 0.00% | +100+10.0% | Added |
| Group One Trading, L.P. | 171 | $1.89K | 0.00% | +171 | New |
| Bank of America Corp | 153 | $1.69K | 0.00% | −16−9.5% | Reduced |
| Simplex Trading, LLC | 17 | $0 | 0.00% | +17 | New |
| Diadema Partners LP | 0 | $0 | 0.00% | −101,502−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −78,949−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −48,352−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −30,300−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −20,761−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,761−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1,703−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |